Skip to main content
. 2017 Mar 31;8(21):34811–34819. doi: 10.18632/oncotarget.16746

Table 3. Incidence density rates and hazard ratios of osteoporosis and fracture in patients with and without HSCT stratified by sex, age, comorbidity, and underlying cancers.

Non-HSCT group HSCT group HR (95% CI) P for interaction
Event no. Person-years IR Event no. Person-years IR Crude Adjusteda
Osteoporosis
Sex 0.91
  Women 74 8915 8.30 27 1500 18.0 2.10 (1.35–3.27)** 2.59 (1.64–4.09)***
  Men 51 13,199 3.86 20 2275 8.79 2.21 (1.31–3.70)** 2.58 (1.51–4.41)***
Age of HSCT (year) 0.003
  < 18 8 6307 1.27 5 576 8.68 5.69 (1.84–17.5)** 5.33 (1.70–16.7)**
  18–50 40 11162 3.58 31 2616 11.9 3.33 (2.08–5.32)*** 3.45 (2.15–5.55)***
  > 50 77 4646 16.6 11 582 18.9 1.10 (0.59–2.06) 1.10 (0.58–2.10)
Comorbidity 0.12
  No 58 16,854 3.44 27 2601 10.4 2.94 (1.86–4.64)*** 2.92 (1.84–4.63)***
  Yes 67 5260 12.7 20 1173 17.1 1.34 (0.82–2.22) 2.02 (1.19–3.42)**
Type of cancer 0.10
  Hematologic malignancy 115 19824 5.80 38 3407 11.2 1.86 (1.29–2.68)** 2.32 (1.59–3.40)***
  Solid tumor 10 2290 4.37 9 368 24.5 5.85 (2.36–14.5)*** 5.92 (2.34–15.0)***
Fracture
Sex 0.13
  Women 28 9107 3.07 6 1596 3.76 1.21 (0.50–2.92) 1.51 (0.61–3.74)
  Men 26 13,276 1.96 13 2293 5.67 2.78 (1.43–5.43)** 3.21 (1.62–6.37)***
Age of HSCT (year) 0.62
  < 18 5 6313 0.79 2 5873 3.41 3.47 (0.66–18.2) 3.41 (0.63–18.5)
  18–50 19 11259 1.69 11 2707 4.06 2.46 (1.17–5.17)* 2.68 (1.26–5.72)*
  > 50 30 4811 6.24 6 595 10.1 1.53 (0.64–3.67) 1.64 (0.67–4.02)
Comorbidityb 0.79
  No 28 16,983 1.65 10 2687 3.72 2.34 (1.09–4.61)* 2.26 (1.09–4.69)*
  Yes 26 5400 4.81 9 1203 7.48 1.52 (0.71–3.25) 1.94 (0.88–4.28)
Type of cancer 0.11
  Hematologic malignancy 49 20087 2.44 14 3504 3.99 1.58 (0.87–2.87) 1.90 (1.03–3.50)*
  Solid tumor 5 2297 2.18 5 385 13.0 6.26 (1.80–21.7)** 5.79 (1.67–20.1)**

HSCT: hematopoietic stem cell transplant; IR: incidence density rate per 1000 person-years; HR: hazard ratio; CI: confidence interval.

aModel mutually adjusting for sex, age, diabetes mellitus, hyperlipidemia, hypertension, coronary artery disease, depression, stroke, chronic obstructive pulmonary disease, chronic kidney disease, and the type of cancer.

bIncluding diabetes mellitus, hyperlipidemia, hypertension, coronary artery disease, depression, stroke, chronic obstructive pulmonary disease, and chronic kidney disease.

*P < 0.05, **P < 0.01, ***P < 0.001.